Role of endogenous peroxisome proliferator-activated receptor-α (PPAR-α) ligands in the development of gut ischemia and reperfusion in mice

被引:20
作者
Muià, C [1 ]
Mazzon, E [1 ]
Crisafulli, C [1 ]
Di Paola, R [1 ]
Genovese, T [1 ]
Caputi, AP [1 ]
Cuzzocrea, S [1 ]
机构
[1] Univ Messina, Sch Med, Dept Clin & Expt Med & Pharmacol, I-98123 Messina, Italy
来源
SHOCK | 2006年 / 25卷 / 01期
关键词
PPAR-alpha; ligand; SAO shock; PPAR-alpha KO mice; TNF-alpha; IL-1; beta; myeloperoxidase activity;
D O I
10.1097/01.shk.0000186930.95227.4f
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
The peroxisome proliferator-activated receptor-alpha (PPAR-alpha) is a member of the nuclear receptor superfamily of ligand-dependent transcription factors related to retinoid, steroid, and thyroid hormone receptors. The aim of the present study was to examine the effects of endogenous PPAR-alpha ligand on the development of gut ischemia and reperfusion injury. Splanchnic artery occlusion (SAO) shock was induced in mice by clamping both the superior mesenteric artery and the celiac artery for 30 min, followed thereafter by release of the clamp (reperfusion). At 60 min after reperfusion, animals were sacrificed for histological examination and biochemical studies. SAO-shocked WT mice developed a significant increase of ileum tissue, TNF-alpha, IL-1 beta, myeloperoxidase activity, and marked histological injury. SAO shock was also associated with a significant mortality (0% survival at 24 h after reperfusion). Reperfused ileum tissue sections from SAO-shocked WT mice showed positive staining for P-selectin, ICAM-1, TNF-alpha, and IL-1 beta. Absence of a functional PPAR-alpha gene in PPAR-alpha K0 mice resulted in a significant augmentation of all the above-described parameters. Thus, endogenous PPAR-a ligands reduce the degree of ileum injury caused by ischemia and reperfusion.
引用
收藏
页码:17 / 22
页数:6
相关论文
共 36 条
[1]
Induction of the expression of the peroxisome proliferator-activated receptor alpha (PPARα) by clofibrate in jerboa tissues [J].
Amsaguine-Safir, S ;
Bianchi, A ;
Collet, P ;
Huin-Schohn, C ;
Jeanvoine, A ;
Bécuwe, P ;
Krémarik-Bouillaud, P ;
Domenjoud, L ;
Keller, JM ;
Schohn, H ;
Dauça, M .
MICROSCOPY RESEARCH AND TECHNIQUE, 2003, 61 (02) :185-190
[2]
Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat [J].
Braissant, O ;
Foufelle, F ;
Scotto, C ;
Dauca, M ;
Wahli, W .
ENDOCRINOLOGY, 1996, 137 (01) :354-366
[3]
BUTCHER EC, 1992, ADV EXP MED BIOL, V323, P181
[4]
WY 14643, a potent exogenous PPAR-α ligand, reduces intestinal injury associated with splanchnic artery occlusion shock [J].
Cuzzocrea, S ;
Di Paola, R ;
Mazzon, E ;
Genovese, T ;
Muià, C ;
Caputi, AP .
SHOCK, 2004, 22 (04) :340-346
[5]
High-density lipoproteins reduce the intestinal damage associated with ischemia/reperfusion and colitis [J].
Cuzzocrea, S ;
Dugo, L ;
Patel, NSA ;
Di Paola, R ;
Cockerill, GW ;
Genovese, T ;
Thiemermann, C .
SHOCK, 2004, 21 (04) :342-351
[6]
Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-γ (PPAR-γ), reduce ischaemia/reperfusion injury of the gut [J].
Cuzzocrea, S ;
Pisano, B ;
Dugo, L ;
Ianaro, A ;
Patel, NSA ;
Di Paola, R ;
Genovese, T ;
Chatterjee, PK ;
Di Rosa, M ;
Caputi, AP ;
Thiemermann, C .
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (02) :366-376
[7]
5-lipoxygenase knockout mice exhibit a resistance to splanchnic artery occlusion shock [J].
Cuzzocrea, S ;
Rossi, A ;
Serraino, I ;
Di Paola, R ;
Dugo, L ;
Genovese, T ;
Caputi, AP ;
Sautebin, L .
SHOCK, 2003, 20 (03) :230-236
[8]
Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of splanchnic artery occlusion and reperfusion [J].
Cuzzocrea, S ;
McDonald, MC ;
Mazzon, E ;
Filipe, HM ;
Costantino, G ;
Caputi, AP ;
Thiemermann, C .
SHOCK, 2000, 14 (02) :150-156
[9]
Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion [J].
Cuzzocrea, S ;
Mazzon, E ;
Dugo, L ;
Caputi, AP ;
Aston, K ;
Riley, DP ;
Salvemini, D .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (01) :19-29
[10]
Cuzzocrea S, 2001, PHARMACOL REV, V53, P135